Pharmicell Co., Ltd. (KRX: 005690)
South Korea
· Delayed Price · Currency is KRW 5,160.00
-40.00 (-0.77%)
Oct 11, 2024, 3:30 PM KST
Pharmicell Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | 2008 - 2005 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '14 Jun 30, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | Dec '09 Dec 31, 2009 | 2008 - 2005 |
| Revenue | 23,945 | 33,405 | 11,112 | 10,282 | 7,217 | 7,188 | Upgrade
|
| Revenue Growth (YoY) | -3.60% | 200.63% | 8.07% | 42.47% | 0.40% | -13.68% | Upgrade
|
| Cost of Revenue | 18,499 | 24,729 | 9,854 | 11,943 | 6,224 | 5,083 | Upgrade
|
| Gross Profit | 5,446 | 8,677 | 1,257 | -1,661 | 993.69 | 2,105 | Upgrade
|
| Selling, General & Admin | 9,368 | 9,892 | 11,154 | 11,604 | 10,370 | 4,104 | Upgrade
|
| Research & Development | 733.81 | 762.26 | 418.36 | 366.6 | - | - | Upgrade
|
| Other Operating Expenses | 42.77 | 41.9 | 148.95 | 89.5 | 27.69 | 174.73 | Upgrade
|
| Operating Expenses | 14,737 | 16,525 | 15,507 | 13,718 | 11,471 | 4,592 | Upgrade
|
| Operating Income | -9,291 | -7,848 | -14,250 | -15,379 | -10,477 | -2,487 | Upgrade
|
| Interest Expense | -1,241 | -1,959 | -1,921 | -1,784 | -1,085 | -660.1 | Upgrade
|
| Interest & Investment Income | 304.49 | 470.98 | 600.2 | 337.09 | 264.31 | 71.85 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | - | -800 | Upgrade
|
| Currency Exchange Gain (Loss) | -100.87 | -1.15 | -35.4 | 1.89 | -53.08 | -3.08 | Upgrade
|
| Other Non Operating Income (Expenses) | 526.06 | 393.31 | -39.59 | 293.73 | 75.38 | 400.6 | Upgrade
|
| EBT Excluding Unusual Items | -9,803 | -8,944 | -15,646 | -16,530 | -11,276 | -3,478 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -30 | 30 | -30 | -419.24 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1,053 | 883.7 | -2.04 | -454.76 | -194.68 | -36.95 | Upgrade
|
| Asset Writedown | -15,793 | -15,793 | - | -772.23 | -75.44 | - | Upgrade
|
| Other Unusual Items | -2,206 | -1,848 | -1,002 | -744.45 | -314.58 | - | Upgrade
|
| Pretax Income | -26,748 | -25,701 | -16,680 | -18,471 | -11,890 | -3,934 | Upgrade
|
| Income Tax Expense | - | - | 969.8 | -285.47 | - | 19.52 | Upgrade
|
| Earnings From Continuing Operations | -26,748 | -25,701 | -17,649 | -18,186 | -11,890 | -3,953 | Upgrade
|
| Net Income to Company | -26,748 | -25,701 | -17,649 | -18,186 | -11,890 | -3,953 | Upgrade
|
| Minority Interest in Earnings | -33.89 | 0.33 | 6.72 | 13.3 | 31.27 | - | Upgrade
|
| Net Income | -26,782 | -25,701 | -17,643 | -18,173 | -11,859 | -3,953 | Upgrade
|
| Net Income to Common | -26,782 | -25,701 | -17,643 | -18,173 | -11,859 | -3,953 | Upgrade
|
| Shares Outstanding (Basic) | 44 | 42 | 38 | 26 | 2 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 44 | 42 | 38 | 26 | 2 | 15 | Upgrade
|
| Shares Change (YoY) | 7.56% | 11.91% | 44.48% | 1161.85% | -86.50% | -8.16% | Upgrade
|
| EPS (Basic) | -613.75 | -607.88 | -467.00 | -695.00 | -5723.00 | -257.52 | Upgrade
|
| EPS (Diluted) | -613.75 | -607.88 | -467.00 | -695.00 | -5723.00 | -257.52 | Upgrade
|
| Free Cash Flow | -7,820 | -3,167 | -14,348 | -16,831 | -8,946 | -5,863 | Upgrade
|
| Free Cash Flow Per Share | -179.21 | -74.90 | -379.79 | -643.69 | -4317.12 | -381.90 | Upgrade
|
| Gross Margin | 22.74% | 25.97% | 11.32% | -16.15% | 13.77% | 29.29% | Upgrade
|
| Operating Margin | -38.80% | -23.49% | -128.24% | -149.57% | -145.16% | -34.59% | Upgrade
|
| Profit Margin | -111.85% | -76.94% | -158.77% | -176.74% | -164.31% | -54.99% | Upgrade
|
| Free Cash Flow Margin | -32.66% | -9.48% | -129.13% | -163.69% | -123.95% | -81.56% | Upgrade
|
| EBITDA | -6,185 | -4,249 | -11,405 | -14,130 | -10,044 | -2,244 | Upgrade
|
| EBITDA Margin | -25.83% | -12.72% | -102.63% | -137.41% | -139.17% | -31.21% | Upgrade
|
| D&A For EBITDA | 3,106 | 3,599 | 2,845 | 1,249 | 432.92 | 242.92 | Upgrade
|
| EBIT | -9,291 | -7,848 | -14,250 | -15,379 | -10,477 | -2,487 | Upgrade
|
| EBIT Margin | -38.80% | -23.49% | -128.24% | -149.57% | -145.16% | -34.59% | Upgrade
|
| Revenue as Reported | - | - | - | - | - | 7,188 | Upgrade
|
| Advertising Expenses | - | 557.28 | 1,361 | 696.1 | 848.23 | 133.72 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.